BLOG: Delight and controversy over new drug to treat Duchenne muscular dystrophy

Dr Karen Anthony, lecturer in molecular bioscience at the University of Northampton, explains the controversy behind a new drug to treat Duchenne muscular dystrophy.   “This week, a drug to treat Duchenne muscular dystrophy (DMD) was granted accelerated approval by the United States Food and Drug Administration (FDA). The long awaited decision on a drug … Continue reading BLOG: Delight and controversy over new drug to treat Duchenne muscular dystrophy